Clinical Trial Update: Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating cisplatin, metronomic low-dose interferon alfa, gemcitabine, and fever-range whole-body hyperthermia for inoperable o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Fever-range whole-body hyperthermia
• Gemcitabine (Gemcitabine)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN